Chronic postsurgical pain

Current Opinion in Anaesthesiology

Volumn 25, Issue 5, 2012, Pages 584-588

  Steyaert, Arnaud ^a   De Kock, Marc ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

central postsurgical pain; inflammatory reaction; methodologies used in acute postoperative pain studies

Indexed keywords

ANALGESIC AGENT; CLONIDINE; ETANERCEPT; GABAPENTIN; HYPNOTIC AGENT; IBUDILAST; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KETAMINE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OPIATE; PREGABALIN; PROPENTOFYLLINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; REMIFENTANIL; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1;

ADJUVANT THERAPY; ANALGESIA; ASTHMA; ASTROCYTE; CACHEXIA; CHRONIC PAIN; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEPRESSION; DRUG EFFICACY; ENTERITIS; FATIGUE; HIGH RISK POPULATION; HUMAN; HYPERALGESIA; HYPERPLASIA; HYPERTENSION; IMMUNOCOMPETENT CELL; INFLAMMATION; INTRAOPERATIVE PERIOD; LONG TERM POTENTIATION; LOW DRUG DOSE; META ANALYSIS (TOPIC); MICROGLIA; MOBILIZATION; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; OBESITY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSYCHOMETRY; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SENSORY SYSTEM; SYNAPTOGENESIS;

ACUTE DISEASE; ANALGESICS; ANALGESICS, OPIOID; CHRONIC PAIN; HUMANS; HYPERALGESIA; INFLAMMATION; PAIN MANAGEMENT; PAIN, POSTOPERATIVE;

EID: 84866364876     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32835743b7     Document Type: Review

References (25)

1. Fortier M, Chou J, Maurer EL, Kain Z. Acute to chronic pain in children: preliminary findings. J Pediatr Surg 2011; 46:1700-1705.
2. Grosu I, De Kock M. New concepts in acute pain management: strategies to prevent chronic postsurgical pain, opioid-induced hyperalgesia and outcomes measures. Reg Analg Acute Pain Manag 2011; 29:311-328.
3. Chan M, Wan A, Gin T, et al. Chronic postsurgical pain after nitrous oxide anesthesia. Pain 2011; 11:2514-2520.
4. WU CL, Raja SN. Treatment of acute postoperative pain. Lancet 2011; 377:2215-2225.
5. Taylor K, Anastakis DJ, Davies KD. Chronic pain and sensory-motor deficits following peripheral nerve injury. Pain 2010; 151:582-591.
6. Jansen KJ, Kalkman CJ, Gobee DE, et al. The risk of severe postoperative pain: modification and validation of a clinical prediction rule. Anesth Analg 2008; 107:1330-1339.
7. Tramer M. Ketamine and postoperative pain-a quantitative systemic review of randomized trials. Pain 2005; 113:61-70.
8. Chapman CR, Donaldson GW, Davis JJ, Bradshaw DH. Improving individual measurement of postoperative pain: the pain trajectory. J Pain 2011; 12:257-262.
9. Omoigui S. The biochemical origin of pain-proposing a new law of pain: the origin of all pain is inflammation and the inflammatory response-a unifying law of pain. Med Hypotheses 2007; 69:70-82.
10. Milligan E, Watkins L. pathological and protective role of glia in chronic pain. Nat Rev Neurosci 2009; 10:22-36.
11. American Academy of Allergy, Asthma & Immunology. Asthma statistics. http://www.aaai.org/media/resources/media-kit/astma-statistics.htm.
12. Waldiceu A, Verri Jr, Cunha T, et al. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development. Pharmacol Ther 2006; 112:116-138.
13. Hu Y, Liang D, Li X, et al. The role of interleukin-1 in wound biology. Anesth Analg 2010; 111:1525-1542.
14. Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1b sensors. J Neurosci 2008; 28:14062-14073.
15. Hutchinson M, Lewis S, Coats B, et al. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav Immun 2009; 23:240-250.
16. Horvath RJ, Landry RP, Romero-Sandoval EA, DeLeo JA. Morphine tolerance attenuates the resolution of postoperative pain and enhances spinal microglial p38 and extracellular receptor kinase phosphorylation. Neuroscience 2010; 169:843-885.
17. Mony L, Kew J, Gunthorpe M, Paoletti P. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol 2009; 157:1301-1317.
18. Lowenstein E, Hallowell P, Levine F, et al. Cardiovascular response to large doses of intravenous morphine in man. N Engl J Med 1969; 281:1389-1393.
19. Ruscheweyth R, Wilder-Smith O, Drdla R, et al. Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy. Mol Pain 2011: 7:1-37.
20. Aubrun F, Valade N, Coriat P, Riou B. Predictive factors of severe postoperative pain in the postanesthesia care unit. Anesth Analg 2008; 106:1535-1541.
21. WongG,Gavva N.Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks. Brain Res Rev 2009; 60:267-277.
22. Kissin I. Vanilloid-induced conduction analgesia: selective, dose-dependent, long-lasting, with low level of potential neurotoxicity. Anesth Analg 2008; 107:271-281.
23. Chahl LA. TRP channels and psychiatric disorders. Adv Exp Med Biol 2011; 704:987-1009.
24. Wang D. TRPV in hypertension, inflammation and end organ damage: an imminent target of therapy for cardiovascular disease. Curr Opin Cardiol 2008; 23:356-363.
25. Borsook D, Becerra LR. Breaking down the barriers: fMRI applications and pain, analgesia and analgesics. Mol Pain 2006; 18:30.